2026 Australia Gold Coast AusBiotech International Biotechnology Conference & Exhibition

The 2026 AusBiotech International Biotechnology Conference & Exhibition in Gold Coast, Australia, as the most influential annual event in the biotechnology sector in Australia and the Asia-Pacific region, brings together leading biotechnology innovators, researchers, investors, policymakers, and industry leaders from around the world. The AusBiotech conference has a long history, and since its establishment, it has been dedicated to promoting the development of Australia's biotechnology industry and fostering international exchange and cooperation. The exhibition is large-scale, attracting thousands of professionals annually, covering the entire industry chain from basic research to clinical application and commercialization. Its influence is reflected not only in the number of exhibitors and attendees but also in its role in guiding industry trends and promoting innovative achievements. The conference typically includes keynote speeches, thematic seminars, company roadshows, one-on-one business meetings, and a large exhibition, providing attendees with a valuable platform to gain in-depth understanding of industry frontiers, expand business networks, and seek cooperation opportunities. Key exhibitors include biopharmaceutical companies, medical device manufacturers, diagnostic technology companies, bioinformatics service providers, contract research organizations (CROs), venture capital firms, government agencies, and major research institutions. This exhibition, located on Australia's Gold Coast, a vibrant city increasingly becoming a hub for scientific research and innovation, will provide attendees with a professional yet comfortable environment for exchange, further enhancing the exhibition's international appeal.

The exhibit range of the 2026 AusBiotech International Biotechnology Conference & Exhibition in Gold Coast, Australia, is extremely broad, covering various sub-markets and cutting-edge technologies in the biotechnology field. Specifically, it includes but is not limited to: Biopharmaceuticals and biologics, such as gene-engineered drugs, vaccines, antibody drugs, cell and gene therapy products, recombinant proteins, blood products, biosimilars; Medical devices and diagnostic technologies, including in vitro diagnostics (IVD) equipment and reagents, molecular diagnostics, gene sequencing equipment, biosensors, microfluidic chips, novel imaging diagnostic technologies, implantable medical devices, wearable medical devices, digital health solutions; Biotechnology R&D services and tools, such as bioreagents, laboratory consumables, bioreactors, fermenters, purification systems, cell culture technologies, proteomics and metabolomics analysis services, high-throughput screening platforms, bioinformatics software and databases, contract research and manufacturing organization (CDMO/CRO) services; Agricultural biotechnology and food biotechnology, covering gene-edited crops, biological pesticides, bio-fertilizers, functional foods, novel food additives, microbial fermented foods; Environmental biotechnology, such as bioremediation technologies, wastewater treatment, waste resource utilization, bioenergy; As well as nanobiotechnology, regenerative medicine, stem cell research, biomaterials, biosafety equipment, intellectual property services, investment and financing services, industrial park promotion, etc. This exhibition will comprehensively showcase the latest breakthroughs and application potential of biotechnology in various fields such such as medicine, agriculture, environment, and food, providing exhibiting companies with an excellent opportunity to display innovative products and solutions, and seek cooperation and investment.

No fee information available. Please contact us for a quote.